Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · IEX Real-Time Price · USD
6.61
-0.02 (-0.30%)
Jun 20, 2024, 2:45 PM EDT - Market open

Acrivon Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current202320222021
Market Capitalization
203109241-
Market Cap Growth
--54.61%--
Enterprise Value
98-14117-94
PE Ratio
-2.52-1.81-7.72-
PB Ratio
1.890.901.41-
P/FCF Ratio
-3.21-2.49-7.45-
P/OCF Ratio
-3.35-2.56-7.99-
EV/EBITDA Ratio
-0.890.24-3.906.12
EV/EBIT Ratio
-0.870.23-3.775.81
EV/FCF Ratio
-1.110.32-3.646.64
Debt / Equity Ratio
0.040.040.03-0.24
Debt / EBITDA Ratio
-0.07-0.08-0.16-0.37
Debt / FCF Ratio
-0.09-0.11-0.15-0.40
Quick Ratio
12.219.6119.6734.31
Current Ratio
12.409.7520.2734.46
Return on Equity (ROE)
-49.70%-42.50%-42.50%100.80%
Return on Assets (ROA)
-45.00%-39.00%-21.70%-29.90%
Return on Capital (ROIC)
-62.60%-53.32%-18.61%89.02%
Earnings Yield
-31.46%-55.30%-12.95%-
FCF Yield
-24.75%-40.23%-13.42%-
Buyback Yield / Dilution
-3.06%-435.63%-136.43%-21.70%
Total Shareholder Return
-3.06%-435.63%-136.43%-21.70%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).